Evidence map›Paper›PMID 36289686›Full record

ArticleBiomedicines2022

MicroRNA Associated with the Invasive Phenotype in Clear Cell Renal Cell Carcinoma: Let-7c-5p Inhibits Proliferation, Migration, and Invasion by Targeting Insulin-like Growth Factor 1 Receptor.

Thomas J Kalantzakos, Luke E Sebel, James Trussler, Travis B Sullivan, Eric J Burks, Carmen D Sarita-Reyes, David Canes, Alireza Moinzadeh, Kimberly M Rieger-Christ

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Thomas J KalantzakosDepartment of Translational Research, Lahey Hospital & Medical Center, Burlington, MA 01805, USA.
Luke E SebelDepartment of Urology, Lahey Hospital & Medical Center, Burlington, MA 01805, USA.
James TrusslerDepartment of Urology, Lahey Hospital & Medical Center, Burlington, MA 01805, USA.
Travis B SullivanDepartment of Translational Research, Lahey Hospital & Medical Center, Burlington, MA 01805, USA.
Eric J BurksDepartment of Pathology & Laboratory Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA 02118, USA.ORCID 0000-0002-3122-2875
Carmen D Sarita-ReyesDepartment of Pathology & Laboratory Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA 02118, USA.ORCID 0000-0002-0821-5052
David CanesDepartment of Urology, Lahey Hospital & Medical Center, Burlington, MA 01805, USA.
Alireza MoinzadehDepartment of Urology, Lahey Hospital & Medical Center, Burlington, MA 01805, USA.
Kimberly M Rieger-ChristDepartment of Translational Research, Lahey Hospital & Medical Center, Burlington, MA 01805, USA.
Lahey Hospital and Medical Center · USBoston University · US

Funding

Morton E. Goulder Research Endowment Fund n/aR.K. Mellon Family Foundation n/aThea Post Foundation n/a
6 · The paper itself

Abstract

Differential microRNA (miRNA) expression can portend clear cell renal cell carcinoma (ccRCC) progression. In a previous study, we identified a subset of dysregulated miRNA in small renal masses, pT1 ccRCC (≤5 cm) that are associated with an aggressive phenotype. The present study investigated miRNA expression in clinical stage I (cT1) tumors (≤5 cm), comparing pathologic stage I (pT1) tumors to those upstaged to pathologic stage 3 (pT3) after surgery following identification of renal vein invasion or invasion into adjacent fat tissue within Gerota's fascia. Twenty cT1 tumors were examined in an miRNA screening, 10 pT1 and 10 pT3 tumors. The ccRCC cell lines 786-O and Caki-1 were used to assess the impact of let-7c-5p and its protein target insulin-like growth factor 1 receptor (IGF1R). Cells were transfected with pre-let-7c-5p and assessed through cell proliferation, migration, and invasion assays. IGF1R expression was evaluated through Simple Western, and interaction between let-7c-5p and IGF1R was confirmed via luciferase reporter assay. Screening identified 20 miRNA, including let-7c-5p, that were dysregulated between pT1 and pT3 upstaged tumors. This miRNA was also downregulated in our previous study of pT1 tumors that progressed to metastatic disease. Transfection of ccRCC cells with pre-let-7c-5p significantly inhibited proliferation, migration, invasion, and IGF1R expression. These findings suggest that miRNA dysregulation is involved in ccRCC progression, specifically through invasion, and that let-7c-5p downregulation contributes to the aggressiveness of small ccRCC tumors, in part, through its regulation of IGF1R.

Indexed as

clear cell renal cell cancer (ccRCC)insulin like growth factor 1 receptor (IGF1R)invasionmicroRNAmigrationproliferation

Identifiers

PMID36289686
PMCPMC9598558
OpenAlexW4297521816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.